Filing Details
- Accession Number:
- 0000920148-11-000101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-15 10:00:34
- Reporting Period:
- 2011-12-13
- Filing Date:
- 2011-12-15
- Accepted Time:
- 2011-12-15 10:00:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1107216 | Orchid Cellmark Inc | ORCH | Services-Testing Laboratories (8734) | 223392819 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | 358 South Main Street Burlington NC 27215 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.001 | Acquisiton | 2011-12-13 | 30,304 | $2.80 | 25,996,016 | No | 4 | P | Indirect | See footnote |
Common Stock, Par Value $.001 | Acquisiton | 2011-12-14 | 134,943 | $2.80 | 26,130,959 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Footnotes
- The Reporting Person is filing this Form 4 on behalf of itself and OCM Acquisition Corp. ("OCM"), a Delaware corporation and a wholly owned subsidiary of the Reporting Person. The shares of common stock to which this Form 4 relates were acquired by OCM during the subsequent offering period of the tender offer for all outstanding shares of common stock of the Issuer, including, to the extent outstanding, the associated preferred stock purchase rights issued under the Rights Agreement, dated July 27, 2001, as amended, between the Issuer and American Stock Transfer & Trust Company, as rights agent (the "Offer"). The Offer was made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated April 19, 2011, which was annexed to and filed with the Schedule TO filed by the Reporting Person with the Securities and Exchange Commission on April 19, 2011.